Latest Breaking News On - David urso - Page 1 : comparemela.com

MEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer Patients

MEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer Patients
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

David ursoRichard ghaliePharma incAcademic gi cancer consortiumClinical study protocolBevacizumab combinationInitial safetyInitial efficacy

MEI Pharma (MEIP) Reports Initial Data from Study of ME-344 in Combination with Bevacizumab

MEI Pharma (MEIP) Reports Initial Data from Study of ME-344 in Combination with Bevacizumab
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Davida walseyDavid ursoRichard ghalieMei pharma incPharma incAcademic gi cancer consortiumClinical study protocolBevacizumab combinationInitial safetyInitial efficacyPrivate securities litigation reform act

MEI Pharma (MEIP) Board Aligns on Strategy to Advance Voruciclib and ME-344

MEI Pharma (MEIP) Board Aligns on Strategy to Advance Voruciclib and ME-344
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

David ursoTaheer datooDavida walseyCompany board of directorsMei pharma incPharma incCable car capitalAnson fundsClinical studyPrivate securities litigation reform act

MEI Pharma Board of Directors Aligns on Strategy to Advance Voruciclib and ME-344

– MEI Pharma Board Unanimously Determines, Based on Clinical Data Results, Not to Proceed with Second Capital Return Under 2023 Anson and Cable Car Cooperation Agreement: Conserving Capital,.

Taheer datooDavid ursoCompany board of directorsPharma incCable car capitalAnson fundsClinical study

MEI Pharma to Present at the Stifel 2024 Virtual Targeted Oncology Forum

MEI Pharma, Inc. , a clinical-stage pharmaceutical company evaluating novel drug candidates to address known resistance mechanisms to standard-of-care cancer therapies, today announced that David.

David ursoPharma incVirtual targeted oncology forum onTargeted oncology forum